Clin2
NCT06383806Possibly a fitRecruiting

Reducing nightmares in adults with narcolepsy

NarcolepsyNarcolepsy Type 1Narcolepsy With CataplexyNarcolepsy Without CataplexyNightmareNightmare Disorder With Associated Other Sleep Disorder

Part of Brain & nervous system, Mental health clinical trials.

This study tests a new behavioral treatment to reduce nightmares in adults with narcolepsy. It aims to help you sleep better and feel more rested.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have been diagnosed with narcolepsy (type 1 or type 2).
  • You have nightmares at least once a week.
  • You are 18 or older, live in the United States, and speak English.
  • Your sleep and psychiatric medications have been stable for at least a month, and you can keep them stable during the study.
  • You are not currently in trauma therapy or sleep therapy, and you haven't had behavioral treatment for nightmares before.
  • If you have sleep apnea, it must be treated (not untreated moderate or severe sleep apnea).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06441864Recruiting
Behavioral treatment for nightmares in REM sleep behavior disorder

This study tests a behavioral therapy (non-drug treatment) for nightmares in people with REM sleep behavior disorder (RBD). It's designed for you and a family member who lives with you.

Salt Lake City, Utah
NCT07288593Not yet recruiting
Sleep and nightmare relief for military members and veterans

This study tests a new approach to help military members and veterans with insomnia and nightmares by targeting the body's 'fight-or-flight' response. The treatment is designed to improve sleep and reduce nightmares.

Bethesda, Maryland
NCT07633301Recruiting· Phase 2
TAK-360 Study for Adults With Narcolepsy Type 1

This study tests a new medication called TAK-360 to help adults with narcolepsy type 1 (a condition that causes extreme daytime sleepiness and sudden muscle weakness called cataplexy) feel more alert during the day. The goal is to see if this treatment is safe and effective for managing narcolepsy symptoms.

Redwood City, California
NCT07455383Recruiting· Phase 3
Testing ALKS 2680 for adults with narcolepsy type 1

This study tests a new medication, ALKS 2680, to see if it helps reduce daytime sleepiness and other symptoms in adults with narcolepsy type 1. It may offer a new treatment option for people with this condition.

Cullman, Alabama
NCT07598708Recruiting· Phase 2/Phase 3
Cleminorexton for Narcolepsy: A New Treatment Study

This study tests whether a new medication called cleminorexton helps people with narcolepsy (a condition causing severe daytime sleepiness) sleep better and feel more alert. You would take this medication instead of your current narcolepsy drugs for several months to see if it works.

Birmingham, Alabama
NCT06797284Recruiting
Light, electrical, and magnetic therapy for sleep issues

This study tests if light, electrical, or magnetic treatments can help people with insomnia, narcolepsy, or REM sleep behavior disorder improve their sleep-wake problems. It compares these gentle brain stimulation methods to understand which works best.

Suzhou, Jiangsu

Hear when a new Narcolepsy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.